{
    "title": "113_hr4287",
    "content": "The \"Independent Innovator and Repurposing Act\" may extend the patent term for the method of using biological products. The \"Independent Innovator and Repurposing Act\" allows for a 5-year extension of a patent for a method of using biological products, provided certain conditions are met. The extension must be applied for by the patent owner before the original expiration date, and the patent must not have already expired or been extended previously. To extend a patent for a method of using biological products under the \"Independent Innovator and Repurposing Act,\" the owner must submit an application to the Director before the original expiration date. The application should include the biological product's identity, the patent details, and proof that the patent was issued to an independent innovator. To extend a patent for a method of using biological products under the \"Independent Innovator and Repurposing Act,\" the owner must submit an application to the Director with proof that the patent was issued to an independent innovator or a qualified small business with an ownership interest. Additionally, an application for commercial marketing of the biological product must have been filed under section 351(a) of the Public Health Service Act, with a minimum of 10 years elapsed since the original submission date. To extend a patent for a method of using biological products under the \"Independent Innovator and Repurposing Act,\" the owner must submit an application with proof of ownership. Additionally, a commercial marketing application for the biological product must have been filed under the Public Health Service Act, with a minimum of 10 years elapsed since the original submission date. The owner of a patent must submit an application for extension based on activities related to the biological product. The Director will determine eligibility solely based on the application's representations. The Director will issue a certificate of extension for 5 years if a patent is eligible and requirements are met. An interim extension of up to one year may be granted if the patent would expire before a decision is made on the application. If an application under subsection (b) would expire before a certificate of extension is issued, the Director can extend the patent for up to one year if eligible. Definitions include \"biological product,\" \"Director,\" and \"independent innovator.\" The term \"Director\" refers to the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office. An \"independent innovator\" is defined as a person or entity who obtains a method of use patent for a biological product and is not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act for the commercial marketing of such biological product. The term \"affiliated\" refers to any relationship of employment, control, or common ownership, whether direct or indirect, including through one or more intermediaries. A \"qualified small business\" is defined as an entity with fewer than 500 employees, including employees of affiliates, and not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act for the commercial marketing of a biological product. A \"business\" is defined as an entity with fewer than 500 employees, not affiliated with the holder of a marketing application approved under section 351(a) of the Public Health Service Act for the commercial marketing of a biological product. This section will take effect on the date of enactment and apply to any unexpired patent issued before, on, or after that date."
}